← Eichor
Study identifier: NCT07705061 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hertel Exophthalmometry Values in Mexican Adults

Condition: Exophthalmometry · Normal Exophthalmometric Values  ·  Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Proptosis assessment using Hertel exophthalmometry is an essential part of the ophthalmic examination, but normal reference values vary among different populations. This observational study aims to establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics (such as age and sex) and systemic diseases. Healthy adult participants and adults with selected systemic conditions will undergo standardized Hertel exophthalmometry measurements. The findings are expected to provide population-specific reference values that may improve the clinical assessment of orbital diseases in the Mexican population.

This description comes directly from the study's public registry record.

Talk to the study team

Roberto Ramirez Hernandez, MD, Ophthalmologist  ·  +525525137712  ·  robert.rami.rr@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

✔ Instituto de Oftalmología Fundación Conde de Valenciana IAPMexico City, Mexico City, MexicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07705061